Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against
FDA Nominee Marty Makary Faces The Senate. Will He Toe The RFK Jr. Line?
A Senate committee will vote Thursday on whether to endorse Dr. Marty Makary as the new commissioner of the Food and Drug Administration.
· 2d · on MSN
Senate Committee Grills Trump FDA Nominee Marty Makary
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines.
· 2d · on MSN
Trump's FDA pick says he'll review whether abortion pill must be dispensed in person again
· 4d · on MSN
Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
· 2d · on MSN
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s former value: Just four years ago, the DNA testing company was worth $6 billion. The company’s plunge follows market shifts, a major data breach, and an expensive foray into drug development.
Dr. Marty Makary is a renowned Johns Hopkins surgeon and President Donald Trump's pick to head the Food and Drug Administration (FDA). He faced senators in a two-hour confirmation hearing Thursday morning taking on topics ranging from medical devices, vapes and food safety to the abortion drug mifepristone.
Donald Trump nominated Dr Marty Makary to lead the Food and Drug Administration, a man who shot to fame by skewering the medical establishment in books and papers and bashing the federal response to COVID-19 on TV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results